nucleocapsid
n
protein
sar
coronaviru
sarscov
major
structur
compon
virion
appear
multifunct
protein
involv
viral
rna
replic
translat
heterogen
nuclear
ribonucleoprotein
hnrnp
relat
premrna
splice
nucleu
translat
regul
cytoplasm
report
base
relev
biophys
biochem
assay
nucleocapsid
protein
sarscov
sarsn
discov
exhibit
high
bind
affin
human
hnrnp
gst
pulldown
result
clearli
demonstr
sarsn
protein
could
directli
specif
bind
human
hnrnp
vitro
yeast
twohybrid
assay
indic
vivo
bind
relat
fragment
aa
sarsn
glyrich
domain
aa
hnrnp
moreov
kinet
analys
surfac
plasmon
reson
spr
technolog
reveal
sarsn
protein
specif
bind
affin
human
hnrnp
k
lm
k
k
suggest
sarsn
hnrnp
protein
possibl
within
sarscov
replicationtranscript
complex
sarsnhuman
hnrnp
interact
might
function
regul
sarscov
rna
synthesi
addit
determin
result
show
sarsn
protein
one
bind
domain
interact
human
hnrnp
differ
mous
hepat
viru
mhv
bind
case
nucleocapsid
protein
mhv
mhvn
found
two
bind
domain
involv
mhvnhnrnp
interact
therebi
suggest
sarsn
protein
might
carri
differ
bind
mode
bind
human
hnrnp
function
perform
comparison
mhvn
end
year
june
year
atyp
pneumonia
refer
sever
acut
respiratori
syndrom
sar
broke
china
countri
known
sar
coronaviru
sarscov
respons
sar
infect
research
show
sarscov
belong
one
member
coronavirida
moder
relat
known
coronavirus
sarscov
open
read
frame
orf
encod
put
protein
includ
four
major
structur
protein
nucleocapsid
n
spike
membran
small
envelop
e
protein
n
protein
sarscov
sarsn
highli
basic
structur
protein
local
cytoplasm
nucleolu
trichoplusia
ni
tn
cell
previou
studi
indic
n
protein
coronavirus
extens
phosphoryl
associ
viral
rna
form
helic
ribonucleoprotein
rnp
compris
viral
core
structur
recent
discov
fact
sarsn
tightli
bind
human
cyclophilin
might
provid
new
hint
understand
possibl
sarscov
infect
pathway
human
cell
sarsn
amino
acid
protein
share
homolog
n
protein
coronavirus
report
nucleocapsid
protein
mhv
mhvn
bind
tandemli
repeat
sequenc
ucyaac
viral
genom
accord
srxx
repeat
region
aa
hand
genom
sequenc
analysi
sarscov
reveal
transcriptionregul
sequenc
end
gene
involv
partial
conserv
core
sequenc
structur
sarsn
own
srxx
repeat
region
share
high
similar
mhvn
protein
accord
sequenc
analysi
therefor
sarsn
predict
interact
viral
rna
involv
mrna
synthesi
transcript
sarscov
human
cell
discov
heterogen
nuclear
ribonucleoprotein
hnrnp
hnrnp
bestcharacter
protein
like
relat
premrna
splice
transport
cellular
rna
research
indic
hnrnp
behav
global
regul
altern
premrna
splice
antagon
activ
sever
serineargininerich
splice
factor
sr
protein
thu
result
activ
abbrevi
sarscov
sever
acut
respiratori
syndrom
coronaviru
n
protein
nucleocapsid
protein
sarsn
nucleocapsid
protein
sar
coronaviru
hnrnp
heterogen
nuclear
ribonucleoprotein
mhv
mous
hepat
viru
spr
surfac
plasmon
reson
iptg
isopropylbd
dgalactosid
altern
distal
splice
site
skip
option
exon
structur
hnrnp
contain
two
rnabind
domain
rbd
glycinerich
domain
respons
proteinprotein
interact
hnrnp
select
interact
glyrich
domain
differ
rnabind
protein
especi
splice
factor
sr
protein
prove
hnrnp
involv
mhv
rna
replic
transcript
certainli
regul
rna
synthesi
cytoplasm
viru
recent
publish
paper
demonstr
nucleocapsid
protein
mhv
could
interact
hnrnp
sinc
sarsn
abl
bind
rna
also
share
homolog
mhvn
think
sarscov
life
cycl
sarsn
might
also
possibl
interact
human
hnrnp
mrna
synthesi
matur
mrna
transport
transcript
current
studi
use
gst
pulldown
yeast
twohybrid
spr
techniqu
discov
sarsn
could
directli
interact
human
hnrnp
vitro
vivo
result
indic
sarsnhuman
hnrnp
interact
involv
srrich
fragment
aa
sarsn
glyrich
domain
aa
hnrnp
therebi
suggest
sarsn
human
hnrnp
protein
possibl
within
sarscov
replicationtranscript
complex
interact
might
function
regul
sarscov
rna
synthesi
similar
mhvn
case
addit
fact
one
hnrnp
domain
sarsn
suggest
sarsn
protein
bind
hnrnp
sarscov
take
differ
mode
comparison
mhvn
gluthation
stransferas
gst
affin
resin
molecular
weight
marker
purchas
amersham
pharmacia
biotech
inc
iptg
purchas
promega
yeast
nitrogen
base
without
amino
acid
yeast
synthet
dropout
medium
supplement
without
tryptophan
yeast
synthet
dropout
medium
supplement
without
leucin
tryptophan
yeast
synthet
dropout
medium
supplement
without
leucin
tryptophan
histidin
purchas
sigma
chemic
co
triazol
sangon
chemic
sigma
analyt
grade
gene
human
hnrnp
gene
bank
access
amplifi
pcr
cdna
librari
hela
cell
primer
amplif
atgtctaagtcagagtctcctaaagagccgaac
ttaaaatcttctgccactgccatagctactgc
amplifi
product
clone
pgem
easi
vector
promega
accord
standard
promega
manual
sequenc
gene
pgem
easi
vector
amplifi
pcr
use
primer
ggctggatccatgtctaagtcagagtctccta
ggtcgaattcttaaaatcttctgccactgccata
amplifi
product
digest
bamhi
ecori
underlin
primer
ligat
amersham
pharmacia
biotech
digest
restrict
enzym
vector
transform
escherichia
coli
novagen
overnight
cultur
singl
coloni
per
ml
lb
medium
contain
lgml
ampicillin
dilut
medium
h
od
reach
express
protein
induc
addit
mm
iptg
cultur
incub
h
aerat
cell
recov
centrifug
quickfrozen
store
overnight
frozen
cell
thaw
resuspend
ml
pb
buffer
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
contain
mm
edta
mm
bmercaptoethanol
per
gram
cell
lyse
sonic
min
ice
bath
lysat
clear
centrifug
supernat
load
onto
glutathionecolumn
amersham
pharmacia
equilibr
pb
buffer
load
column
wash
ml
pb
buffer
gsthnrnp
elut
use
mm
reduc
glutathion
freshli
ad
pb
buffer
glutathion
contain
purifi
protein
remov
dialysi
pb
buffer
purifi
protein
detect
singl
band
sdspage
gel
protein
concentr
measur
absorb
nm
use
extinct
coeffici
lmolcm
recombin
nucleocapsid
protein
sar
coronaviru
sarsn
clone
express
purifi
accord
publish
procedur
report
luo
et
al
gst
pulldown
assay
perform
use
profound
pulldown
gst
protein
protein
interact
kit
pierc
purifi
gsthnrnp
adsorb
onto
glutathionesepharos
bead
equilibr
buph
tb
buffer
mm
trishcl
nacl
ph
handee
minispin
column
serv
bait
protein
subsequ
step
h
bead
carri
gst
fusion
hnrnp
resuspend
wash
solut
tb
profound
lysi
buffer
time
addit
mg
purifi
sarsn
prey
protein
mixtur
gentli
shaken
h
left
addit
min
without
mix
rins
repeat
time
use
wash
solut
mention
bound
protein
elut
mm
glutathion
elut
buffer
elut
sampl
analyz
sdspage
yeast
vector
obtain
clontech
palo
alto
ca
hnrnp
gene
amplifi
follow
primer
ggcggaattcatgtctaagtcagagtctccta
ggtcggatccttaaaatcttctgccactgccata
amplifi
product
digest
ecori
bamhi
neb
usa
clone
vector
two
site
confirm
glyrich
domain
hnrnp
involv
hnrnp
interact
fragment
hnrnp
also
clone
vector
abovement
method
primer
clone
ggccgaattcatgtctaagtcagagtctcctaa
ggctggatccttaaaagtttccagaaccacttc
sarsn
gene
amplifi
follow
primer
gggtgaattcatgtctgataatggaccccaat
aattggatccttatgcctgagttgaatcagcag
amplifi
product
digest
ecori
bamhi
neb
clone
vector
identifi
put
domain
amino
acid
sequenc
requir
hnrnp
interact
differ
fragment
sarsn
gene
prepar
pcr
antisens
primer
sens
primer
fulllength
sarsn
gene
clone
mention
primer
list
tabl
tabl
primer
truncat
fragment
sarsn
use
yeast
twohybrid
compet
cell
yeast
strain
obtain
clontech
plano
alto
ca
transform
perform
accord
protocol
briefli
ng
plasmid
dna
ad
ml
compet
cell
mix
ml
lithium
acet
min
follow
heatshock
min
subsequ
spread
dropoutagar
plate
absenc
leucin
tryptophan
plate
incub
h
yeast
growth
pcr
use
confirm
transform
target
gene
posit
clone
inocul
sd
medium
lack
leucin
typtophan
histidin
sdlth
supplement
mm
triazol
sdlth
medium
shaken
rpm
h
medium
fill
well
micropl
absorb
nm
medium
micropl
measur
tecan
reader
switzerland
altern
method
base
growth
curv
analysi
yeast
cultur
amen
microtit
plate
format
method
use
reproduc
equal
greater
sensit
compar
bgalactosidas
assay
yeast
media
prepar
accord
standard
protocol
handbook
clontech
spr
technolog
base
biacor
biacor
ab
biosensor
use
perform
kinet
analysi
sarsnhuman
hnrnp
interact
research
grade
sensor
chip
purchas
biacor
ab
nhydroxysuccinimid
nethyn
carbodiimid
ethanolamin
coupl
regent
use
immobil
ligand
sensor
surfac
use
standard
aminecoupl
procedur
run
sampl
buffer
mm
hepe
ph
contain
mm
nacl
buffer
filter
degass
use
analyt
inject
ll
follow
dissoci
phase
experi
repeat
least
twice
data
obtain
associ
rate
k
dissoci
rate
k
equilibrium
dissoci
k
k
k
k
constant
obtain
sensorgram
fit
langmuir
bind
model
use
global
fit
method
biaevalu
softwar
bind
affin
synthes
peptid
assrsssrsrgnsrn
human
hnrnp
calcul
steadyst
fit
mode
biaevalu
softwar
inhibitori
assay
peptid
vari
concentr
mix
lm
human
hnrnp
h
inject
biacor
hnrnp
interact
order
identifi
interact
hnrnp
sarsn
recombin
human
gsthnrnp
protein
overexpress
e
coli
follow
purif
use
glutathionesepharos
affin
bead
sarsnhuman
hnrnp
interact
determin
gst
pulldown
assay
purifi
human
gsthnrnp
fig
lane
protein
immobil
glutathionesepharos
bead
bait
protein
accord
kit
histag
sarsn
protein
prey
purifi
ni
affin
column
fig
lane
gsthnrnp
possibl
partner
elut
glutathion
sampl
analyz
sdspage
indic
lane
fig
sarsn
protein
could
also
detect
sdspage
suggest
human
gsthnrnp
elut
glutathion
togeth
sarsn
protein
sarsn
bind
human
hnrnp
could
consid
specif
bead
pull
sarsn
protein
shown
lane
result
therebi
determin
sarsn
protein
could
specif
bind
human
hnrnp
vitro
interact
biacor
employ
biacor
altern
approach
perform
kinet
analysi
sarsnhuman
hnrnp
interact
assay
sarsn
protein
immobil
sensor
chip
ligand
ru
accord
standard
aminecoupl
wizard
control
flow
cell
activ
block
directli
without
immobil
protein
elimin
nonspecif
interact
hnrnp
sensor
chip
surfac
purifi
human
hnrnp
protein
prepar
seri
concentr
analyt
inject
biacor
bind
level
measur
ru
human
hnrnp
immobil
sarsn
rose
reach
satur
increas
concentr
fig
demonstr
human
hnrnp
protein
directli
bind
sarsn
vitro
associ
sarsn
hnrnp
could
describ
simpl
equilibrium
b
ab
kinet
paramet
equilibrium
dissoci
constant
k
associ
rate
constant
k
dissoci
rate
constant
k
sarsnhnrnp
proteinprotein
interact
determin
langmuir
bind
model
evalu
curv
found
fit
experiment
curv
well
fig
fit
reliabl
also
reflect
small
chi
residu
fig
k
sarsn
hnrnp
interact
thu
simul
lm
k
k
quantit
reveal
high
bind
affin
sarsn
human
hnrnp
region
map
yeast
twohybrid
assay
valid
sarsnhnrnp
interact
yeast
twohybrid
assay
technolog
perform
fulllength
sarsn
protein
human
hnrnp
clone
infram
vector
upon
cotransform
plasmid
construct
phenotyp
observ
high
stringenc
nutrit
medium
sdlth
mm
fig
even
higher
stringenc
mm
data
shown
therefor
indic
possibl
presenc
sarsnhnrnp
interact
vivo
moreov
fact
control
empti
plasmid
show
cell
growth
fig
suggest
sarsnhnrnp
interact
might
rel
specif
yeast
map
involv
region
sarsn
within
sarsnhnrnp
interact
seri
nest
fragment
sarsn
gener
fig
fragment
design
clone
vector
cotransform
respect
yeast
cell
growth
high
stringenc
nutrit
medium
sdlth
mm
shake
cell
transfer
micropl
growth
curv
cell
evalu
measur
absorb
nm
micropl
indic
fig
aa
aa
show
viabil
compar
empti
control
thu
suggest
two
segment
sarsn
protein
bind
affin
human
hnrnp
note
delet
fragment
aa
sarsn
result
loss
bind
activ
human
hnrnp
indic
fact
viabil
detect
aa
aa
aa
therefor
suggest
interact
fragment
sarsn
protein
involv
sarsnhuman
hnrnp
interact
probabl
within
segment
aa
addit
found
growth
aa
aa
close
littl
less
fulllength
n
seem
n
termin
amino
acid
residu
sarsn
might
involv
sarsnhnrnp
interact
valid
possibl
made
two
truncat
fragment
sarsn
aa
aa
indic
fig
bind
affin
human
hnrnp
could
bind
human
hnrnp
therebi
indic
n
termin
fragment
particip
sarsnhuman
hnrnp
interact
segment
aa
sarsn
indispens
proteinprotein
interact
explor
possibl
bind
fragment
human
hnrnp
within
sarsnhnrnp
interact
cterminusdelet
fragment
aa
human
hnrnp
studi
fragment
clone
plasmid
cotransform
shown
fig
yeast
cell
contain
show
viabil
lane
n
suggest
aa
hnrnp
might
interact
sarsn
sinc
lot
fact
confirm
hnrnp
protein
interact
select
ctermin
glyrich
domain
differ
rnabind
protein
togeth
result
suggest
ctermin
glyrich
domain
human
hnrnp
may
also
involv
sarsnhuman
hnrnp
interact
hnrnp
interact
notic
srxxrepeat
section
within
fragment
aa
sarsn
srxxrepeat
segment
seem
common
region
hnrnp
bind
protein
report
srxxrepeat
fragment
mhvn
within
mhvnhnrnp
interact
part
therefor
encourag
fact
suppos
srxxrepeat
fragment
sarsn
might
also
involv
sarsnhnrnp
interact
valid
hypothesi
synthes
peptid
assrsssrsrgnsrn
accord
fragment
aa
sarsn
appli
biacor
assay
curv
peptid
bind
immobil
gsthnrnp
flow
cell
immobil
gst
control
shown
fig
bind
affin
peptid
human
hnrnp
protein
thu
evalu
k
lm
steadyst
fit
model
confirm
specif
bind
sarsn
srxxrepeat
domain
hnrnp
also
perform
inhibitori
experi
use
peptid
inhibit
hnrnp
interact
immobil
sarsn
protein
biacor
shown
fig
lm
peptid
perturb
lm
hnrnp
bind
sarsn
protein
therebi
suggest
srxxrepeat
fragment
sarsn
contribut
sarsnhuman
hnrnp
interact
present
studi
employ
seri
biochem
biophys
method
firstli
report
sarsn
protein
specif
bind
affin
human
hnrnp
yeast
twohybrid
assay
demonstr
cterminu
human
hnrnp
fragment
aa
sarsn
probabl
contribut
sarsnhuman
hnrnp
interact
sinc
human
hnrnp
sarsn
protein
bind
rna
implement
function
rna
replic
transcript
thu
tent
propos
togeth
bound
rna
sarsn
might
probabl
interact
human
hnrnp
form
complex
regul
transcript
replic
sarscov
accord
report
model
mhv
therefor
seem
cross
talk
human
hnrnp
sarsn
protein
might
essenti
sarscov
replic
transcript
addit
sarsn
protein
bind
cterminu
human
hnrnp
cooper
hnrnp
recruit
protein
form
transcript
replic
complex
cterminaldelet
mutant
human
hnrnp
interact
sarsn
fail
bring
initi
complex
possibl
result
failur
sarscov
rna
replic
transcript
addit
yeast
twohybrid
result
clearli
indic
one
fragment
sarsn
aa
requir
sarsnhuman
hnrnp
interact
differ
mhvn
case
mhvn
two
domain
aa
aa
involv
bind
hnrnp
fig
suggest
mhvnhnrnp
interact
seem
stronger
comparison
sarsnhnrnp
know
fragment
aa
contain
srxxrepeat
domain
multifunct
conserv
n
protein
coronavirus
work
fact
synthes
srxxrepeat
peptid
weak
bind
affin
k
lm
human
hnrnp
fig
suggest
srxxrepeat
segment
sar
ni
involv
domin
sarsnhuman
hnrnp
interact
also
within
similar
bind
featur
correspond
fragment
mhvn
fig
interestingli
recent
report
srxxrepeat
fragment
indispens
sarsn
multimer
sarsn
interact
sarscov
membran
protein
fact
indic
srxxrepeat
fragment
sarsn
protein
might
play
potent
role
sarscov
infect
even
though
studi
address
explor
sarsn
regul
adapt
interact
differ
partner
conclus
data
shown
first
time
vitro
vivo
nucleocapsid
protein
sar
coronaviru
high
bind
affin
human
hnrnp
proteinprotein
interact
involv
region
aa
sarsn
cterminu
aa
human
hnrnp
base
analyt
result
mhv
suggest
sarsn
human
hnrnp
protein
might
among
sarscov
replicationtranscript
complex
interact
may
involv
regul
sarscov
rna
synthesi
fact
one
instead
two
human
hnrnp
domain
sarsn
indic
sarsn
protein
interact
human
hnrnp
sarscov
might
take
differ
bind
type
compar
mhv
possibl
due
low
sequenc
homolog
sarscov
rel
coronavirus
